Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Nutr ESPEN ; 17: 28-32, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28361744

RESUMO

PROBLEM: Up to 35% of hospitalized patients may experience functional decline during or after hospitalization. Subjective Global Assessment (SGA) and handgrip strength at admission, have been proposed as simple and accessible tools to predict functional decline, but there are few studies in hospitalized patients to confirm these findings. OBJECTIVE: To assess the predictive value of handgrip strength at hospital admission, on functional decline after 30 days. METHODS: 125 non-critical patients hospitalized for medical and surgical conditions, were studied in El Pino hospital in Santiago, Chile. Upon admission, nutritional status was assessed by SGA, functional status through the Karnofsky index (KI), and handgrip strength by dynamometry. Change in functionality was assessed by the difference between KI at admission and 30 days later. Multivariate logistic regression models were used to establish associations between the variables at hospital admission, and subsequent functional decline. RESULTS: Thirty days post-hospital admission, 28.8% of the sample showed functional decline. In a multivariate analysis, only handgrip strength was associated with this decline (ß = -0.025, OR = 0.974 (CI 0.956-0.992), p = 0.007). CONCLUSIONS: Handgrip strength upon hospital admission can be a useful independent and early method to predict deterioration of functional status during hospitalization.


Assuntos
Força da Mão , Dinamômetro de Força Muscular , Admissão do Paciente , Adulto , Idoso , Chile , Comorbidade , Feminino , Humanos , Avaliação de Estado de Karnofsky , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Avaliação Nutricional , Estado Nutricional , Razão de Chances , Valor Preditivo dos Testes , Prognóstico , Fatores de Risco , Fatores de Tempo , Adulto Jovem
2.
Reprod Sci ; 24(4): 635-640, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-27609401

RESUMO

Many pharmacological agents have been investigated to manage preterm labor; we postulate that a combination of tocolytic drugs may achieve a better effect in the prevention of uterine contractions without dose-dependent adverse effects. The aim of this study was to evaluate the inhibitory effect of dual combinations of tocolytics in vitro. Human myometrium was obtained during elective cesarean sections (term without labor; n = 40). Myometrial strips were placed in organ baths for the measurement of isometric tension. Contractile activity was induced by oxytocin (10-8 mol/L), then a concentration-response curve to single or dual combinations of tocolytics was started. All studied tocolytics (nifedipine, ritodrine, nitroglycerin, atosiban, and NS-1619), when used alone, significantly inhibited myometrial contractions. When combined, nifedipine plus ritodrine produced a significantly greater inhibition of contractility than each drug alone in the midrange of concentrations. The combination of nifedipine plus nitroglycerin or nifedipine plus atosiban produced a significantly greater inhibition than nitroglycerin or atosiban alone but not greater than nifedipine. The combination of nifedipine plus NS-1619 (Ca+2-activated K+ [BKCa] channel opener) reduced the inhibitory effect of each drug. We concluded that a selected combination of tocolytics (nifedipine plus ritodrine) produced a significantly greater inhibitory effect on contractility than each drug alone at intermediate concentrations. Thus, specific combinations of tocolytics with different intracellular signaling pathways may have a synergic effect constituting a provocative new option for preterm labor treatment.


Assuntos
Miométrio/efeitos dos fármacos , Nifedipino/farmacologia , Ritodrina/farmacologia , Tocolíticos/farmacologia , Contração Uterina/efeitos dos fármacos , Benzimidazóis/farmacologia , Sinergismo Farmacológico , Feminino , Humanos , Gravidez , Vasotocina/análogos & derivados , Vasotocina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA